Zhengye Biotechnology Holding Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Fiscal Year 2026 Annual Report (Form 20-F) Filing | 30 Apr 2027 |
Monitoring Framework
Key Performance Indicators
Swine Vaccine Revenue Annually90.1M
Poultry Vaccine Revenue Annually12.5M
Other Vaccines Revenue Annually13.7M
Research and Development Expenses Annually18M
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price of Class A ordinary shares below $1.00 for 30 consecutive business daysAction: Regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days before November 25, 2026, potentially utilizing a reverse share split if necessary.
- Board Independence ComplianceTrigger: Board lacking a majority of independent directors following the resignation of Wenbin WangAction: Restore compliance with Nasdaq Listing Rule 5605(b)(1) by appointing a new independent director.
Research as of 19 Jun 2026